Cargando…

Use of Rituximab in child with SLE and myocardial involvement

Detalles Bibliográficos
Autores principales:	Balan, S, Goel, C, Rangaraj, S, Venning, H, Camina, N, Hutchinson, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334058/ http://dx.doi.org/10.1186/1546-0096-6-S1-P251

Ejemplares similares

A rare case of sarcoid osteitis in a child with response to methotrexate
por: Goel, C, et al.
Publicado: (2008)

Organ system-involvement in SLE and relationship with demographic factors, disease duration and health-related quality of life in childhood SLE
por: Moorthy, Lakshmi N, et al.
Publicado: (2012)

Liver involvement in juvenile systemic lupus erythematosus (SLE)
por: Mariniello, Generosa, et al.
Publicado: (2011)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003)

A case with SLE and Pseudohypoparathyreoidism
por: Varbanova, B, et al.
Publicado: (2008)

Use of SIICC / ACR damage index in adolescents with SLE
por: Bogmat, Ludmila, et al.
Publicado: (2014)

Two different cases of SLE with neuropsychiatric manifestation
por: Panaviene, V, et al.
Publicado: (2011)

The effect of Rituximab treatment on T cells
por: Diaz-Torné, C, et al.
Publicado: (2010)

Myocardial tissue characteriation with native myocardial T1 mapping in SLE patients with chest pain
por: Shaw, Jaime L, et al.
Publicado: (2016)

“Brucellupus” in a boy: challenging sle diagnosis in childhood
por: Paganelli, Valeria, et al.
Publicado: (2014)

23. Adult-onset Still’s disease presenting as SLE
por: Ellis, Natalya, et al.
Publicado: (2019)

Persistent sle activity related to untreated reactivation of pulmonary tuberculosis
por: Ho, Assunta Chi Hang
Publicado: (2014)

Atypical onset as predictor of poor outcome in Pediatric Systemic Lupus Erythematosus (pSLE)
por: Taddio, A, et al.
Publicado: (2008)

PReS-FINAL-2284: SLE and complement deficiencies: a French multicentric retrospective study
por: Roland-Gosselin, B, et al.
Publicado: (2013)

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

PReS-FINAL-2355: Comparison of pediatric and adult SLE genetic load
por: Dominguez, MD, et al.
Publicado: (2013)

Psychiatric symptoms as the first manifestation of juvenile SLE complicated with Klinefelter's syndrome
por: Yeganeh, Mehrnoush Hassas, et al.
Publicado: (2014)

SLE‐associated myelitis successfully treated by rituximab
por: Khabbazi, Alireza, et al.
Publicado: (2022)

Small practice effects on neurocognitive testing – markers of early cognitive impairment among adolescents with SLE?
por: Muscal, Eyal, et al.
Publicado: (2012)

The role of cardiac magnetic resonance imaging in the assessment of systemic lupus erythematosis (SLE)
por: Norman, Wendy, et al.
Publicado: (2009)

Safety of rituximab in children with auto-immune diseases
por: Bader-Meunier, B, et al.
Publicado: (2008)

Health related quality of life in juvenile SLE patients– use of the PedsQL 3.0 rheumatology module
por: Sousa, Helena, et al.
Publicado: (2011)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Achieving consensus on quality indicators (QI) for pediatric Systemic Lupus Erythematosus (pSLE)
por: Pendl, Joshua, et al.
Publicado: (2011)

Rituximab reduces the hospitalization in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Analysis of rituximab’s usage for the treatment of pediatric systemic lupus erythematosus
por: Alves, Alessandra, et al.
Publicado: (2014)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

The role of kidney biopsy in a patient with juvenile SLE with no urine abnormity or no signs of renal failure
por: Schüller, M, et al.
Publicado: (2011)

Age related clinical presentation and laboratory parameters in juvenile SLE: a Hungarian multicenter study
por: Derfalvi, B, et al.
Publicado: (2011)

25. Use of rituximab in refractory primary antiphospholipid syndrome with pulmonary and cerebral manifestations
por: Khan, Asim, et al.
Publicado: (2019)

Active regulatory T-cells contribute to broadened T-cell repertoire diversity in ivIg-treated SLE patients
por: Costa, Nuno, et al.
Publicado: (2011)

Metabolic disease with autoimmune phenomena: 2 cases of SLE-like disease in young children diagnosed with lysinuric protein intolerance
por: Sengler, C, et al.
Publicado: (2008)

Traditional cardiovascular risk factors in a cohort of juvenile-onset systemic lupus erythematosus (J-SLE)
por: Rodrigues, Mariana, et al.
Publicado: (2011)

PReS-FINAL-2285: Pediatric non-renal SLE presenting as periorbital edema: response to treatment with belimumab
por: Arabshahi, B
Publicado: (2013)

Valvular disease in patients with active sle and clinical suspicion of acute myocarditis : assesment by cardiovascular magnetic resonance
por: Abarca, Cielmar G
Publicado: (2015)

Rituximab is a therapeutical option for juvenile microscopic polyangiitis
por: Brunner, J, et al.
Publicado: (2008)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Rituximab reduces anti-cardiolipin levels in patients with systemic lupus erythematosus
por: Martínez-Pérez, R, et al.
Publicado: (2010)

Lack of association of hepatitis C virus (HCV) antibodies and juvenile onset systemic lupus erythematosus (jSLE)
por: Goldenstein-Schainberg, Cláudia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nakiqlfjne8lqvrvbiai679ca3